BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 22348366)

  • 1. Anaemia, diabetes and chronic kidney disease: where are we now?
    Stevens PE
    J Ren Care; 2012 Feb; 38 Suppl 1():67-77. PubMed ID: 22348366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia.
    Thomas MC; Tsalamandris C; Macisaac R; Jerums G
    Diabet Med; 2006 May; 23(5):502-9. PubMed ID: 16681558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial.
    Villar E; Lièvre M; Kessler M; Lemaître V; Alamartine E; Rodier M; François M; Zaoui P; Moranne O; Choukroun G; Guerraoui A; Jolivot A; Janin G; Branger B; Heng AE; Boudray C; Bissery A; Rabilloud M; Pouteil-Noble C
    J Diabetes Complications; 2011; 25(4):237-43. PubMed ID: 21601481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial.
    Laville M;
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S18-22. PubMed ID: 15103544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CE: Continuing Education Article: MANAGEMENT OF ANAEMIA IN CHRONIC KIDNEY DISEASE.
    Chamney M; Pugh-Clarke K; Kafkia T; Wittwer I
    J Ren Care; 2010 Jun; 36(2):102-11. PubMed ID: 20591006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaemia in diabetes.
    Thomas S; Rampersad M
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S13-7. PubMed ID: 15103543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anaemia in chronic heart failure].
    Hradec J
    Vnitr Lek; 2010 Aug; 56(8):854-9. PubMed ID: 20845618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment anaemia of chronic kidney disease in predialysis patients (stage 1-4)].
    Lovcić V; Vujić J; Ivanac Janković R; Basić-Jukić N; Barisić I; Lovcić P; Dzapo M
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():11-6. PubMed ID: 20232547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA).
    Goldsmith D; Covic A
    Nephrol Dial Transplant; 2010 Jun; 25(6):1734-7. PubMed ID: 20200007
    [No Abstract]   [Full Text] [Related]  

  • 10. Is normalising haemoglobin in patients with CKD harmful and if so, why?
    Littlewood TJ
    J Ren Care; 2009 Dec; 35 Suppl 2():25-8. PubMed ID: 19891682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy and anaemia.
    Ritz E; Haxsen V
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():66-74. PubMed ID: 16281961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia in diabetes: Is there a rationale to TREAT?
    Thomas MC; Cooper ME; Rossing K; Parving HH
    Diabetologia; 2006 Jun; 49(6):1151-7. PubMed ID: 16586069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality?
    Abaterusso C; Pertica N; Lupo A; Ortalda V; Gambaro G
    Diabetes Obes Metab; 2008 Sep; 10(10):843-9. PubMed ID: 18093210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential roles of erythropoietin in the management of anaemia and other complications diabetes.
    Khoshdel A; Carney S; Gillies A; Mourad A; Jones B; Nanra R; Trevillian P
    Diabetes Obes Metab; 2008 Jan; 10(1):1-9. PubMed ID: 17645562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation.
    Icardi A; Paoletti E; De Nicola L; Mazzaferro S; Russo R; Cozzolino M
    Nephrol Dial Transplant; 2013 Jul; 28(7):1672-9. PubMed ID: 23468534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaemia management in cardio renal disease.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    J Ren Care; 2010 May; 36 Suppl 1():86-96. PubMed ID: 20586904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.
    Hörl WH; Vanrenterghem Y; Canaud B; Mann J; Teatini U; Wanner C; Wikström B
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii25-32. PubMed ID: 15824127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaemia in older people with chronic heart failure: The potential cost.
    Man-Fai Sim V; Nam MC; Riley S; Yousef Z; Hurley J; Cheung WY; O'Mahony S
    Technol Health Care; 2009; 17(5-6):377-85. PubMed ID: 20051617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal anaemia: recent developments, innovative approaches and future directions for improved management.
    Kerr PG
    Nephrology (Carlton); 2006 Dec; 11(6):542-8. PubMed ID: 17199795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.